Navigation Links
HealthAware Introduces Its VascularAware Cardiovascular Disease Module
Date:2/20/2008

DENVER, Feb. 20 /PRNewswire/ -- HealthAware, a leading supplier of innovative services to healthcare providers, announced today the launch of VascularAware, the newest disease module in its Cardiovascular Program. VascularAware is designed to help people who may be at risk for Peripheral Artery Disease (PAD), which affects nearly 10 million adult Americans, according to the American Heart Association.

Development of the VascularAware disease module extends the Company's mission of promoting early detection and prevention of disease.

"PAD affects eight to 12 million people in the U.S., and represents a significant growth market for hospitals," says Greg Gossett, HealthAware President. "According to the Society of Interventional Radiology, PAD impacts 12 to 20 percent of those over age 65, and nearly 20 percent of all men and women age 70 and older."

Mr. Gossett goes on to say, "Through VascularAware, we will be able to better help hospitals attain their goals, while also helping them to increase their visibility and goodwill within their communities."

PAD is a form of atherosclerosis. The most common type of PAD is the hardening and narrowing of arteries that are caused by the gradual buildup of fatty deposits and additional substances. The result is restricted blood flow, mainly in the arteries that lead to the legs and extremities.

Many people with PAD have no symptoms, which is one reason why it is important to screen for this disease through VascularAware. About one third of those with PAD have symptoms in the form of leg pain, cramping, fatigue or other discomfort in the calves or hips when they are walking or engaged in other activity.

However, these symptoms typically will subside when they rest. Because of this, PAD can often go undiagnosed during its early stages because people mistake their symptoms for a form of arthritis or as simply a sign of aging.

By the time people with PAD begin to suffer from s
'/>"/>

SOURCE HealthAware
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Cascade Microtech Introduces Worlds First 45 nm-capable DC/RF Parametric Probe Card Solutions, Lowers Cost of Ownership
2. SoluLinK Introduces ChromaLink(TM) Biotin Labeling Kit to Biotinylate and Measure With One Reagent
3. Biomatrica Introduces SampleWare(R) Version 3.0 Software for Laboratory Sample Management
4. Aton Pharma Introduces Expanded Distribution of Lacrisert(R) (hydroxypropyl cellulose ophthalmic insert) at Hawaiian Eye
5. Biomerica Introduces a New 15 Minute Home Test for Allergies to Cats and Receives CE Mark Approval for Home Use
6. Microfabrica Introduces Set of Miniature Building Blocks for Minimally-Invasive Medical Devices
7. Caliper Life Sciences Introduces Zephyr SPE Workstation to Improve Efficiency of Solid Phase Extraction
8. Finesse Introduces TruBio(TM) IOQ
9. Nikon Instruments Introduces NIS-Elements Software for Eclipse Ti-E Live-Cell Applications
10. EDDA Technology Introduces Universal Enterprise Solution - Enabling 2D/3D/4D Advanced Clinical Applications on Existing PACS Workstations
11. H&V Introduces HVision Technology Platform to Accelerate Development of Breakthrough Products

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...wswire-FirstCall/ - Oncolytics Biotech Inc. ("Onco... announced today that in connection with its previ...ve exercised in full their over-allotment option a...t is comprised of one common share and 0.4 of a co...ce of US$3.00 per unit. Each whole common share pu...
(Date:12/2/2009)..., December 2 Gamida Cell announced...cal (animal study) safety and,efficacy of a gene t...l,Cornell Medical College and Gamida Cell. The pro... such as Cooley,s Anemia. , Gamida Cell i...x vivo,populations of stem/progenitor cells. The ...
(Date:12/2/2009)...ire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: A...aceutical company focused on endocrine therapy and...Drug Administration (FDA) has granted Fast Track d...bitor compound, perifosine (KRX-0401), for the tre...ryx Biopharmaceuticals, Inc. ("Keryx") ( KERX), is...
(Date:12/1/2009)...mon announced that he has joined Carolina Eyecare ... at www.DrKerrySolomon.com , which was developed ...ven LASIK, lens implant, and cataract surgery expe...substantial contributions to improving vision corr...urgeons, which screens LASIK surgeons based upon e...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
...uesday it has authorized a stock repurchase plan p...common stock. Purchases may be made over a period ...epurchases will be based on market conditions, app...continue to explore strategic initiatives designed...y generating positive cash flow from operations. T...
...s and 3M announced Wednesday the signing of a s...mers with the option of coupling its Invader techn... microfluidic technology. , ,Under the agreement, ...Third Wave with its microfluidic technology. This ...laboratories to forgo the numerous liquid-handling...
... agreement Thursday with Capital Data, Inc. , an ...tions and financial services, according to TeraMED...,Through the agreement, Capital Data will bundle T...erprise computing and storage solutions in a terri...ota, South Dakota, Iowa, Illinois and Michigan. , ...
Other Biology Technology:TeraMEDICA and Capital Data enter into diagnostic imaging agreement 2
(Date:12/3/2009)...eam of scientists from the U.S. Department of Ener... University, and the Indian Institute of Science h...s locate the genetic information in DNA that is ne...s. The research, published in the December 1, 2009... , confirms that many proteins responsible for int...
(Date:12/2/2009)...IA Less acculturated Latino men have a more diffi... acculturated to U.S. culture, but acculturation h...Details of these findings are published in Cancer... of the American Association for Cancer Research. ... , "Acculturation affects smoking cessation diff...
(Date:12/2/2009)...IA People who smoke their first cigarette within ... cotinine, a by-product of nicotine when processed...less of the number of cigarettes smoked. , "S... lung cancer, our results suggest that smokers who...at risk for lung cancer," said researcher Joshua E...
Breaking Biology News(10 mins):Grooving down the helix 2Grooving down the helix 3Acculturation affects smoking cessation success among Latinos 2Increased nicotine levels detected in those who light-up earlier 2Campbell Alliance Adds Industry Veterans Jon W McGarity and David Lilley as Executive Vice Presidents 12673 1Campbell Alliance Adds Industry Veterans Jon W McGarity and David Lilley as Executive Vice Presidents 12673 2Campbell Alliance Adds Industry Veterans Jon W McGarity and David Lilley as Executive Vice Presidents 12673 3Campbell Alliance Adds Industry Veterans Jon W McGarity and David Lilley as Executive Vice Presidents 12673 4Campbell Alliance Adds Industry Veterans Jon W McGarity and David Lilley as Executive Vice Presidents 12673 5Campbell Alliance Adds Industry Veterans Jon W McGarity and David Lilley as Executive Vice Presidents 12673 6AMICAS Set to Join Russell 3000 Index 49217 1AMICAS Set to Join Russell 3000 Index 49217 2AMICAS Set to Join Russell 3000 Index 49217 3Alan Stein D D S Opens His Doors and Empties His Pockets 49215 1Alan Stein D D S Opens His Doors and Empties His Pockets 49215 2
...ada has incorporated Earth Observation data into i...he potential of satellites to provide a global and...tainability of business activities. , Companies t...o the long-term quality of life and respect for th... of their Corporate Sustainable Development (CSD) ...
... Md. (March 25, 2008) The American Physiological ...hat it has awarded its 2008 Minority Outreach Fell...s the third year of the award program. , Dr. Gwat...w in the Hypertension and Vascular Research Center...in Winston-Salem, N.C. There she studies the impac...
...ic cropping systems be as productive as convention...alfalfa or wheat and a qualified Yes most of the t...ported by scientists at the University of Wisconsi...in the March-April 2008 issue of Agronomy Journal....results from the Wisconsin Integrated Cropping Sys...
Other Biology News:Satellites take sustainability to new heights 2Satellites take sustainability to new heights 3Satellites take sustainability to new heights 4APS names 2 minority outreach fellows 2APS names 2 minority outreach fellows 3Are organic crops as productive as conventional? 2
Cell Proliferation Kit from GE Healthcare, formerly Amersham Biosciences
Goat Anti-Human Dysadherin 2 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Goat Anti-Human Bcl-2, phospho (Thr74) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-Trx-2 Monoclonal Antibody, Unconjugated, Clone 71G4 from Santa Cruz Biotechnology, Inc.
Biology Products: